Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $78.00 price target on the stock.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com